Ceramide and related-sphingolipid levels are not altered in disease-associated brain regions of APPSL and APPSL/ PS1M146L mouse models of Alzheimer's disease: Relationship with the lack of neurodegeneration?

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Barrier, Laurence ^a   Fauconneau, Bernard ^a   Nol, Anastasia ^a   Ingrand, Sabrina ^a  

^a Service de psychiatrie de l'enfant et de l'adolescent   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CERAMIDE; SPHINGOLIPID;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING;

EID: 79952158162     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/920958     Document Type: Article

References (50)

1. Grsgen S., Grimm M. O. W., Frie P., Hartmann T., Role of amyloid beta in lipid homeostasis Biochimica et Biophysica Acta 2010 1801 8 966 974
2. Hartmann T., Kuchenbecker J., Grimm M. O., Alzheimer's disease: the lipid connection Journal of Neurochemistry 2007 103 159 170
3. Vetrivel K. S., Thinakaran G., Membrane rafts in Alzheimer's disease beta-amyloid production Biochimica et Biophysica Acta 2010 1801 8 860 867
4. Hannun Y. A., Obeid L. M., The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the (Pubitemid 34967060)
5. Schenck M., Carpinteiro A., Grassm H., Lang F., Gulbins E., Ceramide: physiological and pathophysiological aspects Archives of Biochemistry and Biophysics 2007 462 2 171 175 (Pubitemid 46856326)
6. Arboleda G., Morales L. C., Bentez B., Arboleda H., Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration Brain Research Reviews 2009 59 2 333 346
7. Morales A., Lee H., Goi F. M., Kolesnick R., Fernandez-Checa J. C., Sphingolipids and cell death Apoptosis 2007 12 5 923 939 (Pubitemid 46653290)
8. Pettus B. J., Chalfant C. E., Hannun Y. A., Ceramide in apoptosis: an overview and current perspectives Biochimica et Biophysica Acta 2002 1585 2-3 114 125 (Pubitemid 36092075)
9. Cutler R. G., Kelly J., Storie K., Pedersen W. A., Tammara A., Hatanpaa K., Troncoso J. C., Mattson M. P., Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2004 101 7 2070 2075 (Pubitemid 38229016)
10. Jana A., Pahan K., Fibrillar amyloid- peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase: implications for Alzheimer's disease Journal of Biological Chemistry 2004 279 49 51451 51459 (Pubitemid 40017893)
11. Chen S., Lee J. M., Zeng C., Chen H., Hsu C. Y., Xu J., Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes Journal of Neurochemistry 2006 97 3 631 640
12. Grimm M. O. W., Grimm H. S., Ptzold A. J., Zinser E. G., Halonen R., Duering M., Tschpe J. A., De Strooper B., Mller U., Shen J., Hartmann T., Regulation of cholesterol and sphingomyelin metabolism by amyloid- and presenilin Nature Cell Biology 2005 7 11 1118 1123
13. Puglielli L., Ellis B. C., Saunders A. J., Kovacs D. M., Ceramide stabilizes -site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid -peptide biogenesis Journal of Biological Chemistry 2003 278 22 19777 19783 (Pubitemid 36799164)
14. Patil S., Melrose J., Chan C., Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons European Journal of Neuroscience 2007 26 8 2131 2141 (Pubitemid 47620475)
15. Sawamura N., Morishima-Kawashima M., Waki H., Kobayashi K., Kuramochi T., Frosch M. P., Ding K., Ito M., Kim T. W., Tanzi R. E., Oyama F., Tabira T., Ando S., Ihara Y., Mutant presenilin 2 transgenic mice: a large increase in the levels of A 342 is presumably associated with the low density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelin Journal of Biological Chemistry 2000 275 36 27901 27908
16. Tamboli I. Y., Prager K., Barth E., Heneka M., Sandhoff K., Walter J., Inhibition of glycosphingolipid biosynthesis reduces secretion of the -amyloid precursor protein and amyloid -peptide Journal of Biological Chemistry 2005 280 30 28110 28117 (Pubitemid 41076929)
17. Gottfries C. G., Karlsson I., Svennerholm L., Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type International Psychogeriatrics 1996 8 3 365 372 (Pubitemid 27067586)
18. Han X., Holtzman D. M., McKeel D. W., Kelley J., Morris J. C., Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis Journal of Neurochemistry 2002 82 4 809 818
19. Pettegrew J. W., Panchalingam K., Hamilton R. L., Mcclure R. J., Brain membrane phospholipid alterations in Alzheimer's disease Neurochemical Research 2001 26 7 771 782 (Pubitemid 32845968)
20. Satoi H., Tomimoto H., Ohtani R., Kitano T., Kondo T., Watanabe M., Oka N., Akiguchi I., Furuya S., Hirabayashi Y., Okazaki T., Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis Neuroscience 2005 130 3 657 666 (Pubitemid 39601439)
21. Katsel P., Li C., Haroutunian V., Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochemical Research 2007 32 4-5 845 856 (Pubitemid 46481322)
22. Marks N., Berg M. J., Saito M., Saito M., Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: consequences to morphology and viability on enzyme suppression in cultured primary neurons Brain Research 2008 1191 136 147
23. Duyckaerts C., Potier M. C., Delatour B., Alzheimer disease models and human neuropathology: similarities and differences Acta Neuropathologica 2008 115 1 5 38 (Pubitemid 50005258)
24. Higgins G. A., Jacobsen H., Transgenic mouse models of Alzheimer's disease: phenotype and application Behavioural Pharmacology 2003 14 5-6 419 438 (Pubitemid 37176800)
25. Wang G., Silva J., Dasgupta S., Bieberich E., Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes Glia 2008 56 4 449 456 (Pubitemid 351212953)
26. Cheng H., Zhou Y., Holtzman D. M., Han X., Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease Neurobiology of Aging 2010 31 7 1188 1196
27. Barrier L., Ingrand S., Fauconneau B., Page G., Gender-dependent accumulation of ceramides in the cerebral cortex of the APPSL/PS1Ki mouse model of Alzheimer's disease Neurobiology of Aging 2010 31 11 1843 1853
28. Casas C., Sergeant N., Itier J. M., Blanchard V., Wirths O., Van Der Kolk N., Vingtdeux V., Van De Steeg E., Ret G., Canton T., Drobecq H., Clark A., Bonici B., Delacourte A., Benavides J., Schmitz C., Tremp G., Bayer T. A., Benoit P., Pradier L., Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated A accumulation in a novel Alzheimer transgenic model American Journal of Pathology 2004 165 4 1289 1300 (Pubitemid 39297734)
29. Blanchard V., Moussaoui S., Czech C., Touchet N., Bonici B., Planche M., Canton T., Jedidi I., Gohin M., Wirths O., Bayer T. A., Langui D., Duyckaerts C., Tremp G., Pradier L., Time sequence of maturation of dystrophic neurites associated with A deposits in APP/PS1 transgenic mice Experimental Neurology 2003 184 1 247 263 (Pubitemid 37444035)
30. Schmitz C., Rutten B. P. F., Pielen A., Schfer S., Wirths O., Tremp G., Czech C., Blanchard V., Multhaup G., Rezaie P., Korr H., Steinbusch H. W. M., Pradier L., Bayer T. A., Hippocampal neuronal loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimers disease American Journal of Pathology 2004 164 4 1495 1502 (Pubitemid 38387814)
31. Schfer S., Wirths O., Multhaup G., Bayer T. A., Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease Journal of Neural Transmission 2007 114 3 387 394 (Pubitemid 46328658)
32. Wang J., Tanila H., Puolivli J., Kadish I., Van Groen T., Gender differences in the amount and deposition of amyloid in APPswe and PS1 double transgenic mice Neurobiology of Disease 2003 14 3 318 327 (Pubitemid 37543511)
33. Barrier L., Ingrand S., Damjanac M., Rioux Bilan A., Hugon J., Page G., Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease Neurobiology of Aging 2007 28 12 1863 1872 (Pubitemid 47539690)
34. Ladisch S., Gillard B., A solvent partition method for microscale ganglioside purification Analytical Biochemistry 1985 146 1 220 231 (Pubitemid 15093069)
35. Bandaru V. V. R., Troncoso J., Wheeler D., Pletnikova O., Wang J., Conant K., Haughey N. J., ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain Neurobiology of Aging 2009 30 4 591 599
36. Christensen D. Z., Kraus S. L., Flohr A., Cotel M. C., Wirths O., Bayer T. A., Transient intraneuronal A rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice Acta Neuropathologica 2008 116 6 647 655
37. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y., LaFerla F. M., Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A and synaptic dysfunction Neuron 2003 39 3 409 421 (Pubitemid 36937044)
38. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K., Bayer T. A., Intraneuronal A accumulation precedes plaque formation in -amyloid precursor protein and presenilin-1 double-transgenic mice Neuroscience Letters 2001 306 1-2 116 120 (Pubitemid 32524311)
39. Harigaya Y., Saido T. C., Eckman C. B., Prada C. M., Shoji M., Younkin S. G., Amyloid protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain Biochemical and Biophysical Research Communications 2000 276 2 422 427
40. Wirths O., Breyhan H., Cynis H., Schilling S., Demuth H. U., Bayer T. A., Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model Acta Neuropathologica 2009 118 4 487 496
41. Bayer T. A., Wirths O., Review on the APP/PS1KI mouse model: intraneuronal A accumulation triggers axonopathy, neuron loss and working memory impairment Genes, Brain and Behavior 2008 7 supplement 1 6 11
42. Kuo Y. M., Kokjohn T. A., Beach T. G., Sue L. I., Brune D., Lopez J. C., Kalback W. M., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., Roher A. E., Comparative analysis of amyloid- chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimers disease brains Journal of Biological Chemistry 2001 276 16 12991 12998
43. Gntert A., Dbeli H., Bohrmann B., High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain Neuroscience 2006 143 2 461 475 (Pubitemid 44716598)
44. Wirths O., Thelen K., Breyhan H., Luzn-Toro B., Hoffmann K. H., Falkai P., Ltjohann D., Bayer T. A., Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease Experimental Gerontology 2006 41 2 220 224 (Pubitemid 43165695)
45. Christensen D. Z., Bayer T. A., Wirths O., Intracellular A triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease Neurobiology of Aging 2010 31 7 1153 1163
46. Yahi N., Aulas A., Fantini J., How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's amyloid peptide (A1-40) PLoS One 2010 5 2
47. Fewou S. N., Bssow H., Schaeren-Wiemers N., Vanier M. T., Macklin W. B., Gieselmann V., Eckhardt M., Reversal of non-hydroxy: -hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose: ceramide galactosyltransferase Journal of Neurochemistry 2005 94 2 469 481 (Pubitemid 40995262)
48. Hama H., Fatty acid 2-Hydroxylation in mammalian sphingolipid biology Biochimica et Biophysica Acta 2010 1801 4 405 414
49. Matsuda J., Kido M., Tadano-Aritomi K., Ishizuka I., Tominaga K., Toida K., Takeda E., Suzuki K., Kuroda Y., Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse Human Molecular Genetics 2004 13 21 2709 2723 (Pubitemid 39485419)
50. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M. C., Gil R., Pradier L., Hugon J., mTOR/p70S6k signalling alteration by A exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease Journal of Neurochemistry 2005 94 1 215 225 (Pubitemid 40911407)